IRCT20120703010178N20尚未招募3 期
?Evaluation of Safety and efficacy of anakinra utilization in COVID-19, a randomized controlled clinical trial
Persisgen Par Pharmaceutical Company0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age of 18 years or more
- •Elevated C-reactive protein levels
- •Fever or cough or dyspnea
- •SpO2 of 93% or less
- •Confirmed SARS-CoV-2 infection by rt-PCR or radiology
- •PaO2/FiO2 of 300 or less
- •Ability to understand and desire to sign a form of informed consent to participate in the study
排除标准
- •Positive PPD test
- •Active Hepatitis B or C infection, Positive HBV antigen or HCV antigen or HIV infection
- •Thrombocytopenia ( platelet count of 150000 per micL)
- •Leukopenia ( white blood cells of 3.6*10^9)
- •Anemia (hemoglobin of 7.5 g/dL)
- •Elevated liver transaminases of 2 fold or more
- •Active infection based on cultures (not received intravenous antibiotics in previous 8 weeks or oral antibiotics in previous 2 weeks)
- •history of malignancy in previous 5 years based on pathology and radiological data
- •history of anakinra, canakinumab or any interleukin-1 inhibitors administration
- •History of receiving of attenuated vaccine in last 2 weeks or during the study
- •hypersensitivity to any component of the medication
研究者
相似试验
进行中（未招募）
不适用
Efficacy and safety of treatment with Anakinra in patients with CINCA/MUCKLE-WELLS syndrome and systemic juvenile idiopathic arthritisEUCTR2005-004008-36-ITISTITUTO GIANNINA GASLINI
尚未招募
2 期
Evaluation of Safety and Efficacy of a Herbo mineral Formulation for increasing Hemoglobin and Iron Deficiency AnaemiaCTRI/2024/03/064617Dabur India Pvt Ltd
进行中（未招募）
2 期
TO evaluate the safety and efficacy of Unani medicines (Funduq and Shaqaqul) in the management of Male Infertility.CTRI/2017/08/009389Govt Nizamia Tibbi College30
进行中（未招募）
1 期
Safety and efficacy of anakinra treatment for patients with persistent respiratory symptoms post acute covid and immune system activation: the PRECISION double-blind, randomized clinical trialCTIS2023-508123-12-00Hellenic Institute For The Study Of Sepsis182
进行中（未招募）
1 期
Stydy to evaluate the efficacy and security of anakinra for the treatment of unresponsiveness arthritis to conventional treatment in systemic lupus erythematosusMedDRA version: 14.1Level: PTClassification code 10042945Term: Systemic lupus erythematosusSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersSystemic lupus erythematosusEUCTR2011-005392-16-ESDr Josep Ordi Ros